A Study of Olanzapine in Participants With Bipolar Disorder.

Recruiting Observational Study
Bipolar Disorder
No Study Drug Researchers observe your health over time — no experimental treatment is given.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
19 and older
Sex
Any
Study type
Observational
Participants needed
3,000 (estimated)
Sponsor
Boryung Pharmaceutical Co., Ltd · Industry
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial

This study aimed to identify treatment patterns in patients with bipolar disorder receiving olanzapine according to demographic and clinical characteristics and to evaluate the effectiveness of education on weight gain, a side effect of olanzapine, in preventing weight gain.

Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Patients who have signed the informed consent after receiving information about the purpose and method of this study. * Patients diagnosed with bipolar disorder and scheduled to receive olanzapine. * Patients who understand the contents of the survey and can answer the questio…
Contacts

Shinyoung Oh

+82 2-708-8000

syoh@boryung.co.kr

CONTACT